Biovitrum's CEO Martin Nicklasson will give a company presentation at
the 27th Annual J.P. Morgan Healthcare Conference being held  January
12-15, 2009, in San Francisco, USA.

The presentation is scheduled to  take place on Wednesday January  14
at 4:00 p.m. (PST). A live  webcast, as well as an archived, will  be
available via Biovitrums website at www.biovitrum.com.
The presentation  material  will be  available  on  www.biovitrum.com
under the link presentations on the investor relations page.



For more information please contact:
Biovitrum
Göran Arvidson, CFO
Phone: +46 8 697 23 68


About Biovitrum
Biovitrum is a pharmaceutical company  with operations in Sweden  and
in the UK. The company markets a range of specialist pharmaceuticals.
Using  its  expertise  and  experience  Biovitrum  takes   scientific
innovation all the  way to  the market and  to specialist  indication
patients  with  significant  medical  need.  Research  expertise  and
capabilities include  development  and  production  of  biotechnology
therapeutics, as well  as small molecule  discovery and  development.
With revenues  of  approximately  SEK  1.3  billion  and  around  500
employees,  Biovitrum  is   a  significant  international   specialty
pharmaceutical player. Biovitrum's share is listed on the OMX  Nordic
Exchange in Stockholm. For more information go to www.biovitrum.com


This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.
http://hugin.info/134557/R/1281605/286620.pdf


Copyright © Hugin AS 2009. All rights reserved.